Tick-Transmitted Diseases in Dogs: Pathogens, Clinical Signs, and Control

Introduction

Ticks are obligate hematophagous ectoparasites that serve as vectors for a diverse array of bacterial, rickettsial, and protozoan pathogens affecting domestic dogs. The clinical syndromes resulting from these infections range from subclinical carrier states to acute life-threatening disease. Understanding the etiologic agents, transmission dynamics, diagnostic approaches, and evidence-based control measures is essential for veterinary practitioners managing canine patients in endemic regions [1]. This article provides a detailed review of the major [dog tick transmitted diseases] with an emphasis on pathogenesis, clinical presentation, laboratory diagnosis, and integrated management strategies. Cross-references to companion articles on specific pathogens are provided where relevant.

Major Pathogens and Etiology

Bacterial and Rickettsial Agents

Borrelia burgdorferi sensu lato

Lyme borreliosis in dogs is caused primarily by Borrelia burgdorferi sensu stricto in North America and by several genospecies of the B. burgdorferi sensu lato complex in Europe and Asia [1]. The spirochete is transmitted by ixodid ticks of the Ixodes ricinus complex, primarily Ixodes scapularis in eastern North America and Ixodes pacificus in the western United States. The pathogen localizes to connective tissues, joints, and occasionally the kidneys, leading to arthritis, fever, and glomerulonephritis [1]. A detailed discussion of clinical syndromes is provided in the article Tick-Borne Illness in Dogs: Comprehensive Review of Common Pathogens and Clinical Syndromes.

Ehrlichia canis and Related Species

Ehrlichia canis is the etiologic agent of canine monocytic ehrlichiosis, transmitted by the brown dog tick Rhipicephalus sanguineus sensu lato [1]. The organism infects monocytes and macrophages, triggering a multisystemic inflammatory response. Acute, subclinical, and chronic disease phases are recognized. Thrombocytopenia is a hallmark hematologic abnormality [1]. Other ehrlichial species include Ehrlichia ewingii, which infects granulocytes and is transmitted by Amblyomma americanum (the lone star tick), and Ehrlichia chaffeensis, a rare cause of monocytic ehrlichiosis in dogs [1]. The pathophysiologic mechanisms and clinical management are reviewed in the dedicated article Ehrlichia canis and Monocytic Ehrlichiosis in Dogs: Tick-Borne Pathogenesis, Thrombocytopenia, and Clinical Management.

Anaplasma phagocytophilum and Anaplasma platys

Anaplasma phagocytophilum is the causative agent of canine granulocytic anaplasmosis, transmitted primarily by Ixodes species ticks [1]. The pathogen targets neutrophils, causing fever, lethargy, polyarthritis, and thrombocytopenia. Anaplasma platys infects platelets and is transmitted by Rhipicephalus sanguineus, leading to cyclic thrombocytopenia in dogs [1]. A dedicated reference on the latter pathogen can be found in the article Anaplasma platys and Thrombocytotropic Anaplasmosis in Dogs: Tick-Transmitted Pathogenesis and Diagnosis.

Rickettsia rickettsii

Rocky Mountain spotted fever (RMSF) in dogs is caused by Rickettsia rickettsii, an obligate intracellular bacterium transmitted by Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick) in North America [1]. The organism infects vascular endothelial cells, leading to vasculitis, petechiation, edema, and multi-organ dysfunction. Clinical signs include fever, depression, and neurologic deficits [1].

Protozoan Agents

Babesia canis and Babesia gibsoni

Canine babesiosis is a hemoprotozoan disease caused by large and small piroplasms of the genus Babesia. Babesia canis (large form) is transmitted by Dermacentor reticulatus and Rhipicephalus sanguineus, whereas Babesia gibsoni (small form) is transmitted primarily by Rhipicephalus sanguineus and also through direct blood transfer [1]. The parasites invade erythrocytes, leading to hemolytic anemia, hemoglobinuria, fever, and splenomegaly [1]. Coinfections with other tick-borne pathogens are common and can exacerbate clinical severity.

Hepatozoon canis and Hepatozoon americanum

Hepatozoonosis is caused by the apicomplexan protozoan Hepatozoon canis (in the Old World) and Hepatozoon americanum (in the southern United States). Transmission occurs not through tick bite but through ingestion of ticks containing mature oocysts [1]. Clinical signs include fever, myositis, periosteal bone proliferation, and cachexia. The life cycle and blood smear diagnosis are detailed in the article Hepatozoon canis: Tick-Borne Protozoan in Dogs – Blood Smear Diagnosis and Clinical Management.

Epidemiology and Transmission Dynamics

The geographic distribution of each pathogen mirrors the range of its competent tick vector. Rhipicephalus sanguineus is a cosmopolitan tick found in both indoor and outdoor environments, making it a major vector for E. canis, A. platys, and B. gibsoni in tropical and subtropical regions [1]. Ixodes scapularis and I. pacificus are prevalent in temperate North America and are the primary vectors for B. burgdorferi and A. phagocytophilum [1]. Amblyomma americanum is expanding its range and transmits E. ewingii and Francisella tularensis (tularemia) [1].

Transstadial transmission, in which the pathogen persists through molting stages from larva to nymph to adult, is a key feature for many of these agents. Transovarial transmission is documented for R. rickettsii and some Babesia species, allowing vertical maintenance of infection in tick populations [1]. Climate change, habitat fragmentation, and increased wildlife reservoir populations have contributed to the expansion of tick ranges and increased canine exposure risk.

For a broader overview of vector-borne infections and their control, refer to the article Tick-Borne Diseases in Dogs: Comprehensive Review of Common Pathogens, Clinical Syndromes, and Management.

Clinical Signs and Pathophysiology

Clinical manifestations vary widely among the different pathogens and depend on the host immune status, pathogen strain, and presence of co-infections. A summary of common clinical signs is provided in Table 1.

| Pathogen | Primary Target Cells | Common Clinical Signs | |, ---, |, --------, |, ---------, | | B. burgdorferi | Connective tissue, joints, kidneys | Fever, shifting leg lameness, lymphadenomegaly, protein-losing nephropathy | | E. canis | Monocytes/macrophages | Fever, depression, thrombocytopenia, epistaxis, lymphadenopathy, ocular signs (uveitis) | | A. phagocytophilum | Neutrophils | Fever, lethargy, polyarthritis, thrombocytopenia, vomiting | | A. platys | Platelets | Cyclic thrombocytopenia, mild fever, petechiation (usually subclinical) | | R. rickettsii | Vascular endothelium | Fever, petechiation, edema, neurologic signs, myocardial involvement | | B. canis / B. gibsoni | Erythrocytes | Hemolytic anemia, hemoglobinuria, fever, splenomegaly, icterus | | H. canis | Leukocytes (neutrophils) | Fever, myositis, periosteal hyperostosis, cachexia |

Pathophysiologic Mechanisms

The spirochete B. burgdorferi evades immune clearance through antigenic variation of its outer surface proteins (OspA, OspC, VlsE) [1]. In dogs, the most consequential complication is Lyme nephropathy, a membranoproliferative glomerulonephritis driven by immune complex deposition [1].

E. canis infects monocytes and disseminates to the spleen, liver, and lymph nodes. The chronic phase is characterized by bone marrow hypoplasia and pancytopenia, particularly in certain breeds such as German Shepherd Dogs [1].

In babesiosis, erythrocyte lysis results from parasite replication and from immune-mediated destruction of infected and uninfected red blood cells. Cytokine release contributes to systemic inflammation and acute-phase protein production [1].

Diagnostic Approaches

Hematology and Biochemistry

Complete blood count and serum biochemistry are essential first-line tests. Thrombocytopenia is the most consistent abnormality in E. canis, A. phagocytophilum, and A. platys infections [1]. Anemia (regenerative or non-regenerative), leukopenia, and hyperglobulinemia are frequently observed in chronic ehrlichiosis. Hemolytic anemia with spherocytosis and autoagglutination suggests babesiosis. Elevated liver enzymes, azotemia, and proteinuria are noted in Lyme nephropathy and severe systemic infections.

Serologic Testing

Detection of antibodies against tick-borne pathogens is performed using indirect fluorescent antibody (IFA) tests or enzyme-linked immunosorbent assays (ELISAs). Acute and convalescent samples are recommended for definitive diagnosis. Cross-reactivity can occur between E. canis and E. ewingii or A. phagocytophilum and A. platys [1]. The presence of antibodies alone does not confirm active infection; a positive serology in a clinically compatible case is highly supportive.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting species-specific gene sequences (e.g., 16S rRNA for Anaplasmataceae, 18S rRNA for Babesia, flaB for Borrelia) provide high sensitivity and specificity for detecting active infection [1]. Whole blood (EDTA) is the preferred sample for E. canis, Anaplasma spp., and Babesia spp., while synovial fluid or tissue may be required for B. burgdorferi detection due to low blood-borne spirochetemia in immunocompetent dogs.

Blood Smear Examination

Giemsa- or Diff-Quik-stained thin blood smears can reveal intracellular organisms in neutrophils (E. ewingii, A. phagocytophilum), monocytes (E. canis), platelets (A. platys), or erythrocytes (Babesia spp.). Sensitivity is limited in low-level parasitemia or bacteremia, especially in chronic infections [1].

A diagnostic workflow for suspected tick-borne disease is depicted in Figure 1.

flowchart TD
    A[Dog with clinical signs - fever, lameness, thrombocytopenia], > B[History of tick exposure?]
    B, >|Yes| C[Perform CBC, biochemistry, urinalysis]
    B, >|No| D[Consider other differentials]
    C, > E{Thrombocytopenia present?}
    E, >|Yes| F[IFA or ELISA for E. canis, A. phagocytophilum, A. platys]
    E, >|No| G[Evaluate for other signs]
    F, > H[PCR panel for Anaplasmataceae, Babesia, Borrelia]
    C, > I[Synovial fluid analysis if lameness]
    I, > J[PCR for B. burgdorferi, A. phagocytophilum]
    H, > K[Positive: initiate appropriate therapy]
    H, > L[Negative with strong clinical suspicion: repeat serology 2-4 weeks later]

For a comprehensive overview of diagnostic testing, refer to Tick-Borne Diseases in Dogs: Curability, Common Pathogens, and Diagnostic Testing and Tick-Borne Diseases in Dogs: Clinical Syndromes and Diagnostic Approaches.

Treatment Strategies

Antibiotic Therapy

Doxycycline (10 mg/kg orally every 12-24 hours for 21-28 days) is the cornerstone therapy for E. canis, E. ewingii, A. phagocytophilum, A. platys, and R. rickettsii infections [1]. For B. burgdorferi, doxycycline is also effective, though the optimal duration is debated; 30 days is commonly recommended. In young dogs or those intolerant to doxycycline, amoxicillin or cefovecin may be used for Lyme disease, but efficacy is lower.

Antiprotozoal Therapy

For canine babesiosis, imidocarb dipropionate (5-6.6 mg/kg intramuscularly or subcutaneously once, repeated in 14 days) is the drug of choice for B. canis [1]. For B. gibsoni, combination therapy with atovaquone (13.3 mg/kg orally every 8 hours) and azithromycin (10 mg/kg orally every 24 hours) for 10 days has shown efficacy [1]. Hepatozoonosis is notoriously difficult to treat. Decoquinate (10-20 mg/kg orally every 12 hours) combined with clindamycin (10 mg/kg orally every 12 hours) and trimethoprim-sulfadiazine (15 mg/kg orally every 12 hours) is used for H. canis, while a combination of ponazuril (5 mg/kg orally every 24 hours) and toltrazuril has been tried for H. americanum [1].

Supportive Care

Fluid therapy, blood transfusions for severe anemia, corticosteroids for immune-mediated sequelae (such as in Lyme nephropathy or immune-mediated hemolytic anemia secondary to babesiosis), and gastroprotectants are often indicated.

A detailed treatment protocol for each major pathogen is available in Tick-Borne Illnesses in Dogs: A Comprehensive Clinical Review of Pathogens and Treatment Protocols and Tick-Borne Diseases in Dogs: Comprehensive Pathogen List, Curability, and Clinical Management.

Control and Prevention

Tick Control in the Environment

Integrated tick management includes habitat modification (brush clearing, leaf litter removal, and exclusion of dogs from heavily tick-infested areas) and use of acaricides on premises [1]. Environmental treatment with permethrin-based products can reduce tick populations, although resistance has been reported in some Rhipicephalus populations.

Acaricide Use on Dogs

Topical spot-on formulations containing fipronil, imidacloprid, permethrin, or fluralaner provide rapid killing of attached ticks. Oral isoxazoline compounds (afoxolaner, fluralaner, sarolaner, lotilaner) have become widely used due to their long duration of action (4-12 weeks) and high efficacy against multiple tick species [1]. Monthly administration is recommended for optimal protection. Collars impregnated with flumethrin and imidacloprid (marketed under various brands) provide continuous repulsion and killing of ticks for up to 8 months [1].

Vaccination

A recombinant OspA vaccine for prevention of canine Lyme borreliosis is available in some regions. The vaccine induces antibodies that neutralize spirochetes in the tick midgut, thereby reducing transmission [1]. Vaccination is recommended for dogs living in or traveling to highly endemic areas. Vaccination strategies are reviewed in Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Updated Vaccination Protocols, though that article focuses on leptospirosis, the same principles apply.

Owner Education

Owners should be counseled on tick checks after outdoor activity, prompt removal of attached ticks using fine-tipped tweezers, and the use of year-round tick prevention products. Additional resources for pet owners are available in articles such as Tick Prevention for Dogs and Cats: A Pet Owner Guide, Top Flea And Tick Prevention For Dogs, and Safe Flea And Tick Prevention For Dogs.

Conclusion

Tick-transmitted diseases in dogs encompass a complex group of infections caused by bacterial, rickettsial, and protozoan pathogens. Accurate diagnosis relies on a combination of serologic, molecular, and hematologic methods. Treatment is generally effective for acute bacterial and rickettsial infections, but protozoal infections such as babesiosis and hepatozoonosis pose therapeutic challenges. Prevention through consistent use of acaricides and avoidance of tick habitats remains the most effective strategy. Veterinary clinicians should maintain a high index of suspicion in dogs with compatible clinical signs and appropriate geographic exposure, and utilize available diagnostic panels to guide therapy.

References

[1] Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Saunders Elsevier; 2012.

[2] Little SE, Eberhard ML, Ewing SA. Diagnostic parasitology for veterinary technicians. St. Louis, MO: Mosby; 2008.

[3] Barr SC, Bowman DD. Canine and feline infectious diseases and parasitology. Ames, IA: Wiley-Blackwell; 2011.

[4] Sykes JE. Canine and feline infectious diseases. St. Louis, MO: Saunders; 2014.

[5] Shaw SE, Day MJ. Arthropod-borne infectious diseases of the dog and cat. London: Manson Publishing; 2005.

[6] Deplazes P, Eckert J, von Samson-Himmelstjerna G, et al. Parasitology in veterinary medicine. Wageningen: Wageningen Academic Publishers; 2016.

[7] Taylor MA, Coop RL, Wall RL. Veterinary parasitology. 4th ed. Ames, IA: Wiley-Blackwell; 2016.

[8] Lappin MR, ed. Small animal internal medicine. 6th ed. St. Louis, MO: Elsevier; 2020.

[9] Bowman DD. Georgis’ parasitology for veterinarians. 10th ed. Saunders; 2018.

[10] Merck Veterinary Manual. 11th ed. Kenilworth, NJ: Merck & Co.; 2020. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.